Heron Therapeutics Inc (HRTX)
2.59
-0.05
(-1.89%)
USD |
NASDAQ |
Apr 22, 16:00
2.59
0.00 (0.00%)
After-Hours: 20:00
Heron Therapeutics Cash from Investing (TTM): 18.00M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 18.00M |
September 30, 2023 | 28.85M |
June 30, 2023 | 16.03M |
March 31, 2023 | 22.56M |
December 31, 2022 | -3.324M |
September 30, 2022 | -29.60M |
June 30, 2022 | 28.08M |
March 31, 2022 | 48.02M |
December 31, 2021 | 32.73M |
September 30, 2021 | 113.78M |
June 30, 2021 | 148.08M |
March 31, 2021 | 140.80M |
December 31, 2020 | 208.96M |
September 30, 2020 | 25.81M |
June 30, 2020 | -1.509M |
March 31, 2020 | 7.922M |
December 31, 2019 | -21.78M |
September 30, 2019 | 112.90M |
June 30, 2019 | -64.98M |
March 31, 2019 | -204.15M |
December 31, 2018 | -278.55M |
September 30, 2018 | -307.24M |
June 30, 2018 | -87.38M |
March 31, 2018 | 12.36M |
December 31, 2017 | 7.738M |
Date | Value |
---|---|
September 30, 2017 | 32.91M |
June 30, 2017 | -68.85M |
March 31, 2017 | -52.70M |
December 31, 2016 | 14.88M |
September 30, 2016 | -46.35M |
June 30, 2016 | -15.45M |
March 31, 2016 | -33.98M |
December 31, 2015 | -56.96M |
September 30, 2015 | -1.563M |
June 30, 2015 | -1.393M |
March 31, 2015 | -1.709M |
December 31, 2014 | -1.438M |
September 30, 2014 | -0.584M |
June 30, 2014 | -1.479M |
March 31, 2014 | -1.307M |
December 31, 2013 | -1.685M |
September 30, 2013 | -1.944M |
June 30, 2013 | -1.046M |
March 31, 2013 | -0.984M |
December 31, 2012 | -0.972M |
September 30, 2012 | -0.933M |
June 30, 2012 | -0.98M |
March 31, 2012 | -0.936M |
December 31, 2011 | -0.513M |
September 30, 2011 | -0.129M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-64.98M
Minimum
Jun 2019
208.96M
Maximum
Dec 2020
43.75M
Average
25.81M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
United Therapeutics Corp | -719.60M |
Esperion Therapeutics Inc | 42.50M |
Aldeyra Therapeutics Inc | 30.00M |
Ocular Therapeutix Inc | -6.087M |
Clearside Biomedical Inc | -1.777M |